The National Institutes of Health (NIH) has announced the discontinuation of its K12 grant program. This program has been a significant funding source for early-career clinical researchers for more than two decades, providing essential support for their training and development.
The termination of the K12 grant is expected to have a notable impact on the pipeline of clinical scientists. This program was particularly crucial for individuals from underrepresented backgrounds, offering them a pathway into clinical research careers. Its absence may create new challenges for diversity and inclusion in the field.
For over 20 years, the K12 grant has played a vital role in fostering the next generation of clinical researchers. It provided structured training and mentorship opportunities, enabling young scientists to establish their research programs and contribute to medical advancements. The decision to end this program raises concerns about future support mechanisms for budding clinical investigators.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
The National Institutes of Health (NIH) is ending its K12 grant program, which has supported early-career clinical researchers for over two decades. This decision will impact the training and career paths of aspiring clinical scientists, particularly those from underrepresented backgrounds.